Results 91 to 100 of about 26,051 (185)

Amyloid Light Chain Amyloidosis Involving the Heart and Temporal Arteries, Mimicking Giant Cell Arteritis

open access: yesJACC: Case Reports
Background: Amyloid light chain (AL) amyloidosis is an uncommon multisystem condition. We report a globally unique case of a patient with AL amyloidosis affecting the heart and temporal arteries.
Ameer Rashed, MBBS, BSc   +5 more
doaj   +1 more source

Early‐Onset Wild‐Type Transthyretin Amyloidosis Polyneuropathy

open access: yes
Muscle &Nerve, Volume 74, Issue 5, Page 1471-1475, November 2026.
Chafic Karam   +7 more
wiley   +1 more source

Multimodality Imaging in Monoclonal Gammopathy of Undetermined Significance and ATTR Wild-Type Cardiac Amyloidosis

open access: yesLife
Amyloidosis is characterized by the tissue deposition of insoluble fibrils derived from misfolded proteins. This case report describes a Hispanic man diagnosed with both monoclonal gammopathy of undetermined significance (MGUS) and wild-type ...
Amalia Peix   +9 more
doaj   +1 more source

Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States

open access: yesClinicoEconomics and Outcomes Research, 2019
Tiffany P Quock,1 Tingjian Yan,2 Ryan Tieu,2 Anita D’Souza,3 Michael S Broder21Medical Affairs, Prothena Biosciences Inc, South San Francisco, CA, USA; 2Health Services Research, Partnership for Health Analytic Research, LLC, Beverly Hills, CA, USA;
Quock TP   +4 more
doaj  

SYSTEMIC AMYLOIDOSIS PRESENTING WITH LYMPHADENOPATHY: A DIAGNOSTIC OVERLAP WITH MULTIPLE MYELOMA AND POSSIBLE CARDIAC INVOLVEMENT

open access: yesHematology, Transfusion and Cell Therapy
Introduction: Systemic amyloidosis is a condition where amyloid proteins accumulate in organs and tissues, causing multisystem dysfunction. Its presentation often overlaps with other conditions like lymphoproliferative disorders and multiple myeloma (MM).
Naciye Nur Tozluklu   +3 more
doaj   +1 more source

Myocardial Perfusion in Cardiac Amyloidosis

open access: yesEuropean Journal of Heart Failure
Abstract Aims Cardiac involvement is the main driver of clinical outcomes in systemic amyloidosis and preliminary studies support the hypothesis that myocardial ischaemia contributes to cellular damage.
Chacko, Liza   +29 more
openaire   +4 more sources

True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis

open access: yesHaematologica, 2018
Avinainder Singh   +7 more
doaj   +1 more source

Cardiac amyloidosis in a Swiss autopsy cohort – distribution and clinical relevance

open access: yesSwiss Medical Weekly
AIMS: Cardiac amyloidosis (CA) characterised by myocardial amyloid accumulation is likely underdiagnosed. The distribution and extent of myocardial amyloid deposits remain unclear.
Albert Baschong   +7 more
doaj   +1 more source

Cardiac Amyloidosis in a Horse [PDF]

open access: yesJournal of Veterinary Internal Medicine, 2003
Yvette S, Nout   +4 more
openaire   +2 more sources

Fulminant cardiac amyloidosis

open access: yesEuropean Heart Journal - Case Reports, 2021
Carlos Real   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy